Invokana: first sodium-glucose co-transporter 2 inhibitor for type 2 diabetesReduces plasma glucose by decreasing renal reabsorption and increasing urinary excretion of glucose. Drug News: May 2014A review of launches, new indications, Health Canada advisories and new dosage guidelines Press Review - May 30, 2014 Management of adult acne Treatment principles are similar to those in younger patients, but hormonal therapy plays a greater role Prepping for a drug holiday The low-T debate The Medical Post table of contents: May 20, 2014 print edition The T Trial Managing testosterone deficiency: What do the guidelines say? RNAO issues key recommendations to help prevent childhood obesity First Previous 130 131 132 133 134 Next Last
